Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» United Therapeutics licenses Pluristem lung disease treatment in deal that could top $55M
United Therapeutics licenses Pluristem lung disease treatment in deal that could top $55M
United Therapeutics licenses Pluristem lung disease treatment in deal that could top $55M
Submitted by
admin
on June 20, 2011 - 9:26am
Source:
Yahoo/AP
News Tags:
United Therapeutics
Pluristem
PAH
Headline:
United Therapeutics licenses Pluristem lung disease treatment in deal that could top $55M
Do Not Allow Advertisers to Use My Personal information
